BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24919588)

  • 1. Minocycline and cisplatin exert synergistic growth suppression on hepatocellular carcinoma by inducing S phase arrest and apoptosis.
    Liu FY; Wu YH; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Huang ZY
    Oncol Rep; 2014 Aug; 32(2):835-44. PubMed ID: 24919588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
    El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
    Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.
    Hossain MA; Kim DH; Jang JY; Kang YJ; Yoon JH; Moon JO; Chung HY; Kim GY; Choi YH; Copple BL; Kim ND
    Int J Oncol; 2012 May; 40(5):1636-42. PubMed ID: 22322725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
    You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
    Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells.
    Zhao JL; Zhao J; Jiao HJ
    Appl Biochem Biotechnol; 2014 Jan; 172(2):784-91. PubMed ID: 24122665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
    Dong X; Liu F; Li M
    Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.
    Fang EF; Zhang CZ; Zhang L; Fong WP; Ng TB
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1351-60. PubMed ID: 22554586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
    Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
    Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J
    Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
    Lu S; Gao Y; Huang X; Wang X
    Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase.
    Liao B; Liang H; Chen J; Liu Q; Zhang B; Chen X
    Tumour Biol; 2015 Dec; 36(12):9347-56. PubMed ID: 26108995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma.
    Huynh H; Chow PK; Tai WM; Choo SP; Chung AY; Ong HS; Soo KC; Ong R; Linnartz R; Shi MM
    J Hepatol; 2012 Mar; 56(3):595-601. PubMed ID: 22027573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
    Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
    Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
    Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of acriflavine in human hepatocellular carcinoma cells.
    Lee CJ; Yue CH; Lin YY; Wu JC; Liu JY
    Anticancer Res; 2014 Jul; 34(7):3549-56. PubMed ID: 24982368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
    Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
    Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.